Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ya Yu

Showing results (511-520 of 520) with videos related to

Pageof 52
Sort By:
You have reached the last page of results.This site can display upto 520 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2011
The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testingPaul D P Pharoah, Rachel T Palmieri, Susan J Ramus, et al.
Nature Genetics|September 21, 2010
A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24Ellen L Goode, Georgia Chenevix-Trench, Honglin Song, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 26, 2015
Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer RiskSiddhartha P Kar, Jonathan P Tyrer, Qiyuan Li, et al.
Nature Genetics|March 29, 2013
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancerPaul D P Pharoah, Ya-Yu Tsai, Susan J Ramus, et al.
Plos One|June 20, 2015
Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) RiskGanna Chornokur, Hui-Yi Lin, Jonathan P Tyrer, et al.
Nature Communications|September 23, 2015
Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancerKate Lawrenson, Qiyuan Li, Siddhartha Kar, et al.
Oncotarget|August 18, 2016
Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancerShalaka S Hampras, Lara E Sucheston-Campbell, Rikki Cannioto, et al.
Nature Communications|March 29, 2013
Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31Jennifer Permuth-Wey, Kate Lawrenson, Howard C Shen, et al.
Nature Genetics|January 13, 2015
Identification of six new susceptibility loci for invasive epithelial ovarian cancerKaroline B Kuchenbaecker, Susan J Ramus, Jonathan Tyrer, et al.
Journal of Medical Genetics|September 7, 2016
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGSMelissa C Southey, David E Goldgar, Robert Winqvist, et al.
Pageof 52

Showing results (511-520 of 520) with videos related to

Sort By:
Pageof 52
You have reached the last page of results.This site can display upto 520 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2011
The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testingPaul D P Pharoah, Rachel T Palmieri, Susan J Ramus, et al.
Nature Genetics|September 21, 2010
A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24Ellen L Goode, Georgia Chenevix-Trench, Honglin Song, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 26, 2015
Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer RiskSiddhartha P Kar, Jonathan P Tyrer, Qiyuan Li, et al.
Nature Genetics|March 29, 2013
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancerPaul D P Pharoah, Ya-Yu Tsai, Susan J Ramus, et al.
Plos One|June 20, 2015
Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) RiskGanna Chornokur, Hui-Yi Lin, Jonathan P Tyrer, et al.
Nature Communications|September 23, 2015
Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancerKate Lawrenson, Qiyuan Li, Siddhartha Kar, et al.
Oncotarget|August 18, 2016
Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancerShalaka S Hampras, Lara E Sucheston-Campbell, Rikki Cannioto, et al.
Nature Communications|March 29, 2013
Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31Jennifer Permuth-Wey, Kate Lawrenson, Howard C Shen, et al.
Nature Genetics|January 13, 2015
Identification of six new susceptibility loci for invasive epithelial ovarian cancerKaroline B Kuchenbaecker, Susan J Ramus, Jonathan Tyrer, et al.
Journal of Medical Genetics|September 7, 2016
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGSMelissa C Southey, David E Goldgar, Robert Winqvist, et al.
Pageof 52